| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Zhejiang Jianfeng Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.95 |
| 52 Week High | CN¥12.15 |
| 52 Week Low | CN¥7.80 |
| Beta | 0.54 |
| 11 Month Change | -8.52% |
| 3 Month Change | -14.24% |
| 1 Year Change | -30.81% |
| 33 Year Change | -33.81% |
| 5 Year Change | -37.15% |
| Change since IPO | -38.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600668 | CN Industrials | CN Market | |
|---|---|---|---|
| 7D | 0% | 1.7% | -1.4% |
| 1Y | -30.8% | 10.5% | -19.1% |
Return vs Industry: 600668 underperformed the CN Industrials industry which returned 10.5% over the past year.
Return vs Market: 600668 underperformed the CN Market which returned -19.1% over the past year.
Price Volatility
| 600668 volatility | |
|---|---|
| 600668 Average Weekly Movement | 3.4% |
| Industrials Industry Average Movement | 4.4% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 600668 has not had significant price volatility in the past 3 months.
Volatility Over Time: 600668's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 1,978 | Jian Hong Yu | www.jianfeng.com.cn |
Zhejiang Jianfeng Group Co., Ltd. operates in the cement business in China. It offers ordinary Portland, Portland slag, and other cement products. The company also provides medical products, including sodium hyaluronate eye drops for dry eyes; calculus bovis factitious; Henopokan for patients with severe herpes zoster; and yu feng ning xin di wan for high blood pressure, dizziness, headache, neck pain, coronary heart disease, angina, nervous headache, and early sudden deafness.
Zhejiang Jianfeng Group Co., Ltd. Fundamentals Summary
| 600668 fundamental statistics | |
|---|---|
| Market cap | CN¥2.74b |
| Earnings (TTM) | CN¥73.03m |
| Revenue (TTM) | CN¥2.89b |
37.5x
P/E Ratio0.9x
P/S RatioIs 600668 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600668 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.89b |
| Cost of Revenue | CN¥2.26b |
| Gross Profit | CN¥623.80m |
| Other Expenses | CN¥550.77m |
| Earnings | CN¥73.03m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 28, 2024
| Earnings per share (EPS) | 0.21 |
| Gross Margin | 21.60% |
| Net Profit Margin | 2.53% |
| Debt/Equity Ratio | 10.6% |
How did 600668 perform over the long term?
See historical performance and comparison